Neurimmune AG today announced that it has entered into an exclusive global collaboration and license agreement with Alexion, AstraZeneca’s Rare Disease group, to develop NI006, an investigational human monoclonal antibody specifically targeting misfolded transthyretin. NI006 is currently in Phase ...
AstraZeneca Lebanon topped the list of the best places to work in Lebanon for 2018, according to the annual Workplace program driven by the global research firm BPTW in partnership with Best Companies Group USA. Best Places to Work ...